Buchumschlag

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients

TO THE EDITOR:Patients with hematological neoplasms, including lymphoma patients, have a high risk for severe COVID-19 diseases.1-4 COVID-19 vaccinations induce strong serologic and T-cell responses in immunocompetent humans and thereby effectively prevent severe COVID-19 disease courses.5-8 There i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Liebers, Nora (VerfasserIn) , Speer, Claudius (VerfasserIn) , Benning, Louise (VerfasserIn) , Bruch, Peter-Martin (VerfasserIn) , Krämer, Isabelle (VerfasserIn) , Meißner, Julia (VerfasserIn) , Schnitzler, Paul (VerfasserIn) , Kräusslich, Hans-Georg (VerfasserIn) , Dreger, Peter (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Poschke, Isabel (VerfasserIn) , Dietrich, Sascha (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 2022
In: Blood
Year: 2022, Jahrgang: 139, Heft: 1, Pages: 142-147
ISSN:1528-0020
DOI:10.1182/blood.2021013445
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.2021013445
Volltext
Verfasserangaben:Nora Liebers, Claudius Speer, Louise Benning, Peter-Martin Bruch, Isabelle Kraemer, Julia Meissner, Paul Schnitzler, Hans-Georg Kräusslich, Peter Dreger, Carsten Mueller-Tidow, Isabel Poschke, and Sascha Dietrich
Beschreibung
Zusammenfassung:TO THE EDITOR:Patients with hematological neoplasms, including lymphoma patients, have a high risk for severe COVID-19 diseases.1-4 COVID-19 vaccinations induce strong serologic and T-cell responses in immunocompetent humans and thereby effectively prevent severe COVID-19 disease courses.5-8 There is accumulating evidence that humoral immune responses after vaccination are impaired in patients with hematological malignancies, especially if they were treated with B-cell-depleting therapies such as anti-CD20 antibodies.9-11 However, there is limited information about the T-cell-mediated vaccine responses after anti-CD20 treatment. In this study, we investigated the humoral and cellular responses after COVID-19 vaccination in lymphoma patients who had received anti-CD20 treatment.
Beschreibung:Prepublished online on Blood first edition 20 October 2021
Gesehen am 16.09.2022
Beschreibung:Online Resource
ISSN:1528-0020
DOI:10.1182/blood.2021013445

Ähnliche Einträge